ABCL - AbCellera Biologics Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$8.00
DETAILS
HIGH:
$9.00
LOW:
$7.00
MEDIAN:
$8.00
CONSENSUS:
$8.00
DOWNSIDE:
13.98%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 75.1 | 28.8 | 38.0 | 485.4 | 375.2 | 233.2 | 11.6 | 8.8 |
| Cost of Revenue | 28.8 | 0 | 0 | 66.4 | 45.5 | 27.1 | 0 | 0 |
| Gross Profit | 46.3 | 28.8 | 38.0 | 419.0 | 329.7 | 206.0 | 11.6 | 8.8 |
| Operating Expenses | ||||||||
| R&D Expenses | 186.8 | 167.3 | 175.7 | 107.9 | 62.1 | 29.4 | 10.1 | 5.8 |
| SG&A Expenses | 76.6 | 85.5 | 75.2 | 66.8 | 48.8 | 15.8 | 4.0 | 2.9 |
| Other Expenses | 0 | 90.8 | 24.4 | 27.8 | 14.5 | 4.8 | 1.6 | 0.9 |
| Operating Expenses | 263.4 | 343.6 | 275.2 | 202.5 | 125.3 | 50.0 | 15.7 | 9.6 |
| Operating Income | ||||||||
| Operating Income | (217.1) | (314.8) | (237.2) | 216.5 | 204.4 | 156.0 | (4.1) | (0.8) |
| Interest Expense | 0 | 0 | 0 | 4.0 | 5.2 | 6.5 | 0.2 | 0.2 |
| Interest Income | 28.3 | 38.5 | 42.2 | 16.1 | 3.3 | 0.3 | 0.2 | 0.0 |
| Profitability | ||||||||
| EBITDA | (148.8) | (204.1) | (192.2) | 260.2 | 239.1 | 169.6 | (0.2) | 1.4 |
| EBIT | (177.6) | (301.1) | (223.1) | 227.1 | 221.9 | 164.3 | (2.0) | 0.5 |
| Income Before Tax | (177.6) | (200.4) | (174.0) | 239.1 | 219.1 | 157.8 | (2.2) | 0.3 |
| Income Tax Expense | (31.2) | (37.5) | (27.6) | 80.6 | 65.7 | 38.9 | 0 | 0 |
| Net Income | (146.4) | (162.9) | (146.4) | 158.5 | 153.5 | 118.9 | (2.2) | 0.3 |
| Per Share Data | ||||||||
| EPS (Basic) | -0.49 | -0.55 | -0.51 | 0.56 | 0.56 | 0.32 | -0.01 | 0.00 |
| EPS (Diluted) | -0.49 | -0.55 | -0.51 | 0.50 | 0.48 | 0.45 | -0.01 | 0.00 |
| Shares Outstanding | 298.7 | 294.3 | 289.2 | 285.1 | 275.8 | 267.8 | 215.4 | 151.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 128.5 | 156.3 | 133.3 | 386.5 | 476.1 | 594.1 | 7.6 | 10.4 |
| Short-Term Investments | 405.3 | 469.3 | 627.3 | 499.9 | 246.8 | 0 | 0 | 0 |
| Net Receivables | 153.4 | 92.1 | 64.4 | 103.4 | 174.9 | 213.7 | 2.1 | 1.4 |
| Inventory | 6.3 | 0 | 1.1 | 1.5 | 1.7 | 1.4 | 0.2 | 0 |
| Other Current Assets | 34.7 | 33.6 | 45.9 | 25 | 25 | 0 | 2.3 | 2.8 |
| Total Current Assets | 728.2 | 751.4 | 872.0 | 1,025.5 | 929.8 | 813.3 | 12.6 | 15.2 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 428.0 | 340.4 | 287.7 | 217.3 | 111.6 | 17.9 | 8.5 | 6.3 |
| Goodwill | 47.8 | 47.8 | 47.8 | 47.8 | 47.8 | 31.5 | 0 | 0 |
| Intangible Assets | 38.4 | 42.1 | 120.4 | 131.5 | 148.4 | 115.2 | 0 | 0 |
| Long-Term Investments | 62.6 | 82.3 | 65.9 | 72.5 | 50.3 | 20.0 | 0 | 0 |
| Other Non-Current Assets | 51.9 | 96.5 | 94.2 | 41.0 | 23.2 | 1.7 | 2.4 | 0 |
| Total Non-Current Assets | 628.7 | 609.2 | 616.1 | 515.4 | 388.8 | 192.2 | 10.8 | 6.3 |
| Total Assets | 1,357.0 | 1,360.6 | 1,488.1 | 1,540.9 | 1,318.6 | 1,005.5 | 23.5 | 21.5 |
| Current Liabilities | ||||||||
| Account Payables | 25.2 | 34.4 | 25.5 | 14.8 | 14.9 | 7.3 | 1.6 | 1.5 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0.2 | 2.5 | 2.5 |
| Deferred Revenue | 22.5 | 21.2 | 19.0 | 21.6 | 7.5 | 7.5 | 0 | 2.3 |
| Other Current Liabilities | 0 | 8.1 | 60.7 | 69.8 | 54.8 | 9.1 | 3.4 | 0.1 |
| Total Current Liabilities | 64.3 | 76.6 | 119.0 | 118.3 | 120.7 | 103.5 | 7.9 | 6.4 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 2.2 | 1.4 | 0.9 |
| Deferred Tax Liabilities | 9.1 | 10.1 | 30.6 | 33.2 | 37.4 | 26.2 | 0 | 0 |
| Other Non-Current Liabilities | 4.8 | 1.5 | 10.8 | 19.1 | 37.6 | 13.6 | 1.3 | 0.3 |
| Total Non-Current Liabilities | 325.7 | 227.9 | 216.8 | 189.3 | 172.2 | 71.5 | 5.3 | 3.4 |
| Total Liabilities | 390.0 | 304.5 | 335.8 | 307.6 | 292.8 | 175.0 | 13.2 | 9.9 |
| Stockholders' Equity | ||||||||
| Common Stock | 802.3 | 777.2 | 753.2 | 734.4 | 722.4 | 710.4 | 5.1 | 5.1 |
| Retained Earnings | (29.5) | 116.9 | 279.8 | 426.2 | 267.7 | 114.2 | (4.7) | (2.5) |
| Accumulated Other Comprehensive Income | (4.2) | (4.4) | (1.7) | (1.4) | 0.3 | 0 | 0 | 0 |
| Total Stockholders' Equity | 966.9 | 1,056.1 | 1,152.3 | 1,233.3 | 1,025.7 | 830.5 | 10.3 | 11.6 |
| Total Liabilities & Equity | 1,357.0 | 1,360.6 | 1,488.1 | 1,540.9 | 1,318.6 | 1,005.5 | 23.5 | 21.5 |
| Debt Metrics | ||||||||
| Total Debt | 143.2 | 65.4 | 77.4 | 82.3 | 40.1 | 6.8 | 6.9 | 3.4 |
| Net Debt | 14.7 | (91.0) | (55.9) | (304.3) | (436.1) | (587.3) | (0.7) | (7.0) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | (146.4) | (162.9) | (146.4) | 158.5 | 153.5 | 118.9 | (2.2) | 0.3 |
| Depreciation & Amortization | 22.2 | 97.0 | 30.9 | 33.1 | 17.2 | 5.3 | 1.8 | 0.9 |
| Stock-Based Compensation | 55.8 | 67.6 | 64.2 | 49.5 | 30.6 | 8.4 | 0.9 | 0.6 |
| Change in Working Capital | (70.7) | (25.8) | 13.2 | 29.8 | 41.7 | (116.7) | 2.0 | 1.9 |
| Other Non-Cash Items | 7.8 | (84.4) | (7.7) | 8.5 | 3.6 | 4.7 | 0.2 | (0.2) |
| Operating Cash Flow | (131.3) | (108.6) | (43.9) | 277.4 | 244.6 | 22.7 | 2.7 | 3.6 |
| Investing Activities | ||||||||
| Capital Expenditure | (42.8) | (78.4) | (77.5) | (72.7) | (58.5) | (14.7) | (4.0) | (5.3) |
| Acquisitions | (7.1) | (19.6) | (13.7) | (25.7) | (11.5) | (106.9) | 0 | 0 |
| Purchases of Investments | (453.1) | (765.1) | (1,066.2) | (781.4) | (322.6) | 0 | 0 | 0 |
| Sales/Maturities of Investments | 506.1 | 948.8 | 910.9 | 510.6 | 27.6 | 0 | 0 | 0 |
| Other Investing Activities | 84.7 | 35.7 | 25.3 | 16.4 | 32.6 | (3.2) | (1.8) | 0 |
| Investing Cash Flow | 87.8 | 121.4 | (221.1) | (352.6) | (332.2) | (119.8) | (5.8) | (5.3) |
| Financing Activities | ||||||||
| Net Debt Issuance | 0 | 13.5 | 11.6 | 2.8 | (1.0) | 85.2 | 0.2 | 2.0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 14.1 | (0.7) | (1.2) | (4.4) | (7.5) | 1 | 0.0 | 0.0 |
| Financing Cash Flow | 14.1 | 12.8 | 10.4 | (1.6) | (3.9) | 683.7 | 0.2 | 12.2 |
| Cash Position | ||||||||
| Net Change in Cash | (28.4) | 23.0 | (254.0) | (86.5) | (93.0) | 586.6 | (2.9) | 10.4 |
| Cash at Beginning | 183.6 | 160.6 | 414.6 | 501.1 | 594.1 | 7.6 | 10.4 | (0.0) |
| Cash at End | 155.2 | 183.6 | 160.6 | 414.6 | 501.1 | 594.1 | 7.6 | 10.4 |
| Free Cash Flow | (174.1) | (187.0) | (121.4) | 204.7 | 186.1 | 8.0 | (1.3) | (1.7) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 75.1 | 28.8 | 38.0 | 485.4 | 375.2 | 233.2 | 11.6 | 8.8 |
| Gross Profit | 46.3 | 28.8 | 38.0 | 419.0 | 329.7 | 206.0 | 11.6 | 8.8 |
| Operating Income | (217.1) | (314.8) | (237.2) | 216.5 | 204.4 | 156.0 | (4.1) | (0.8) |
| Net Income | (146.4) | (162.9) | (146.4) | 158.5 | 153.5 | 118.9 | (2.2) | 0.3 |
| EPS (Diluted) | -0.49 | -0.55 | -0.51 | 0.50 | 0.48 | 0.45 | -0.01 | 0.00 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 128.5 | 156.3 | 133.3 | 386.5 | 476.1 | 594.1 | 7.6 | 10.4 |
| Total Assets | 1,357.0 | 1,360.6 | 1,488.1 | 1,540.9 | 1,318.6 | 1,005.5 | 23.5 | 21.5 |
| Total Debt | 143.2 | 65.4 | 77.4 | 82.3 | 40.1 | 6.8 | 6.9 | 3.4 |
| Stockholders' Equity | 966.9 | 1,056.1 | 1,152.3 | 1,233.3 | 1,025.7 | 830.5 | 10.3 | 11.6 |
| Cash Flow | ||||||||
| Operating Cash Flow | (131.3) | (108.6) | (43.9) | 277.4 | 244.6 | 22.7 | 2.7 | 3.6 |
| Capital Expenditure | (42.8) | (78.4) | (77.5) | (72.7) | (58.5) | (14.7) | (4.0) | (5.3) |
| Free Cash Flow | (174.1) | (187.0) | (121.4) | 204.7 | 186.1 | 8.0 | (1.3) | (1.7) |